Study on the effect of topical Nepafenac 0.1% w/v in preventing Macular edema after cataract surgery in patients with diabetes

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Clinical study evaluates nepafenac's role in reducing macular edema after cataract surgery in diabetic patients, suggesting potential benefits.

Nepafenac 0.1% significantly reduces macular edema in diabetic patients post-cataract surgery.
The study showed improved visual acuity and reduced macular thickness in patients treated with nepafenac.
Patients treated with nepafenac showed no complications, confirming its safety for use in this context.
Optical coherence tomography was pivotal in assessing macular thickness before and after surgery.

Ramalingam et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Clinical study evaluates nepafenac's role in reducing macular edema after cataract surgery in diabetic patients, suggesting potential benefits.